Endocrine

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/58

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

59 Terms

1
New cards

Insulin

released from beta cells of the islets of Langerhans, used for glucose uptake by the liver and transported into skeletal muscle and adipose tissue

2
New cards

glucagon

released from alpha cells of the islets of Langerhans in the pancreas to break down glycogen and release glucose into the blood stream

3
New cards

How does the liver increase glycogen synthesis?

Increases enzyme activity that converts glucose to glycogen, inhibits glycogenolysis, and increases the synthesis and storage of triglycerides and formation of VLDL

4
New cards

How does insulin impact the muscle and adipose tissue

recruits GLUT4 transporters to the plasma membrane and promotes synthesis

5
New cards

What is the pharmacologic treatment for diabetes besides insulin?

oral antidiabetic drugs, incretin mimetic, amylinomimetic

6
New cards

What are biguanides?

most common oral antidiabetic, often used as first line to reduce hepatic gluconeogenesis and insulin resistance via GLUT-4 transporters

7
New cards

True or false: biguanides (metformin) causes hypoglycemia and weight gain

false: metformin does not do these

8
New cards

What are sulfonylureas?

antidiabetic med that stimulates release of insulin from functioning pancreatic beta cells

9
New cards

Examples of sulfonylureas (antidiabetics)

glipizide (glucotrol), glyburide (micronase, DiaBeta)

10
New cards

What are the concerns of sulfonylureas (antidiabetic)?

hypoglycemia in the malnourished older adult or those with liver problems, weight gain

11
New cards

Meglitinides have a similar therapeutic effect to sulfonylureas (antidiabetic), what are the advantages?

reduced risk of hypoglycemia, less weight gain

12
New cards

What are thiazolidinediones (TZDs)?

increases muscle, liver, and adipose tissue sensitivity to insulin

13
New cards

Examples of thiazolidinediones (TZDs)

rosiglitazone (avandia), pioglitazone (actos)

14
New cards

What are the concerns with thiazolidinediones (TZDs)?

weight gain, fluid retention

15
New cards

What is an advantage of thiazolidinediones?

improvement in lipid profile

16
New cards

What are alpha-glucosidase inhibitors?

inhibit the enzyme alpha-glucosidase which is responsible for carbohydrate breakdown to glucose in order to be absorbed into bloodstream

17
New cards

Where do alpha-glucosidase inhibitors act in the body?

intestine

18
New cards

What are some examples of alpha-glucosidase inhibitors?

acarbose (precose), miglitol (glyset)

19
New cards

What are the concerns with alpha glucosidase inhibitors?

GI symptoms due to fermentation of unabsorbed carbohydrates by bacteria in the colon, hypoglycemia if administered with other things

20
New cards

True or false: when alpha glucosidase inhibitors are administered alone, there is a risk of hypoglycemia

false: there is only a risk if administered with other things

21
New cards

What are dipeptidyl peptidase-IV inhibitors?

glucagon-like peptide-1 (GLP 1) is released by endocrine cells in small intestine and increases insulin release, slows gastric emptying, inhibit glucagon secretion and produce sense of satiety

22
New cards

What is the therapeutic effect of dipeptidyl peptidase-IV inhibitors?

inhibits dipeptidyl peptidase-IV, the enzyme responsible for breakdown of glucagon-like peptide (GLP-1)

23
New cards

What is the concern with dipeptidyl peptidase-IV inhibitors?

GI distress

24
New cards

Examples of dipeptidyl peptidase-IV inhibitors

sitagliptin (januvia) and saxagliptin (onglyza)

25
New cards

What are sodium-glucose co-transports?

co-transporter that is located in the proximal nephron in kidney that reabsorbs majority of glucose that is filtered

26
New cards

What are sodium-glucose co-transport 2 inhibitors?

inhibit co-transporter to increase the excretion of glucose in the urine to lower blood glucose levels

27
New cards

Examples of sodium-glucose co-transporter 2 inhibitors

canaglifozin (invokana), dapagliflozin (farxiga), empaglifozin (jardiance)

28
New cards

What are the concerns with SLGT2 inhibitors?

acute kidney injury, hypotension

29
New cards

What is the advantage with SLGT2 inhibitors?

possible reduction in weight and blood pressure without hypoglycemia

30
New cards

What is the therapeutic effect of incretin mimetic?

exerts similar effects as GLP-1

31
New cards

Example of incretin mimetic

exenatide (byetta)

32
New cards

How is incretin mimetic administered and why is it important?

injection because an oral or IV form would degrade too quickly

33
New cards

What are the concerns with incretin mimetics?

nausea/vomiting, hypoglycemia if administered with sulfonylurea

34
New cards

What are amylinomimetics?

synthetic analog of amylin, which prolongs gastric emptying and reduces glucagon secretion after a meal

35
New cards

example of amylinomimetic

pramlintide (symlin)

36
New cards

W\hat is the concern with amylinomimetic?

if administered with insulin, insulin dose must be reduced to avoid hypoglycemia

37
New cards

How is dosing expressed for insulin and how is it adminstered?

units, IV or insulin pump

38
New cards

What is the purpose of ultra-rapid acting insulin?

therapeutic effect is to dissolve rapidly at site of administration to lower blood sugar immediately before meals

39
New cards

Examples of ultra-rapid acting insulin

insulin lispro (humalog), insulin aspart (novolog), insulin glulisine (apidra)

40
New cards

What is the onset of action for ultra-rapid insulin?

5 minutes, peak action is 1 hour, lasts for 3-5 hours

41
New cards

true or false: rapid acting insulin is the same as regular insulin

true

42
New cards

What is the therapeutic effect of rapid acting insulin?

lower blood sugar 1+ hours before a meal

43
New cards

What is the onset of action for rapid-acting insulin?

onset action is 30 minutes, peak is 2 hours, lasts for 6-8 hours

44
New cards

Examples of rapid-acting insulin

humulin R, nobolin R

45
New cards

What is the purpose of an NPH insulin (intermediate acting)?

slows absorption of insulin, is added to regular insulin

46
New cards

What is the onset of action for intermediate acting insulin?

onset is 1-4 hours, peak is 6-12, duration is 14-24 hours

47
New cards

Examples of intermediate-acting insulin

humulin N, novolin N

48
New cards

What is the onset of action of long-acting insulin?

onset is 4-6 hours, peak is 8-20, duration is up to 36 hours

49
New cards

Examples of long-acting insulin

insulin glargine (lantus), insulin detemir (levemir)

50
New cards

What are the general adverse effects of insulin?

hypoglycemia, weight changes, seizures, dizziness, visual disturbance

51
New cards

true or false: Exercise improves insulin sensitivity

true: it stimulates GLUT-4 transporters in muscle and improves glycogen storage

52
New cards

What are statins?

HMG-CoA reductase inhibitors that competitively inhibit the process for biosynthesis of cholesterol in the liver

53
New cards

Side effects of statins

liver abnormalities, muscle pain, food/drug interactions (grapefruit), GI disturbance

54
New cards

What is ezetimibe?

LDL lowering agent that helps avoid large doses of statins

55
New cards

What is the therapeutic effect of ezetimibe?

cholesterol absorption inhibitor in the intestine, impairs dietary and biliary cholesterol absorption

56
New cards

How are hypothyroid conditions managed?

synthetic T4 levothyroxine

57
New cards

What is the first line of therapy for osteoporosis?

oral bisphosphonates that inhibit osteoclast recruitment

58
New cards

Examples of oral bisphosphonates for osteoporosis

alendronate, risedronate

59
New cards

Side effects of oral bisphosphonates

esophagitis, nausea, abdominal pain, osteonecrosis of the jaw